 |
市場調查報告書
商品編碼
1935125
獸用原料藥市場按類型、動物種類、劑型、治療用途、給藥途徑、生產類型、銷售管道及地區分類Veterinary API Market, By Type, By Animal Type, By Formulation, By Therapeutic Application, By Route of Administration, By Manufacturing Type, By Sales Channel, By Geography |
||||||
預計到 2026 年，獸用原料藥市場規模將達到 99.7 億美元，到 2033 年將達到 164.3 億美元，2026 年至 2033 年的複合年成長率為 7.4%。
| 報告內容 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 99.7億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 預測期（2026-2033年）複合年成長率： | 7.40% | 2033 年的預測值： | 164.3億美元 |
全球獸用原料藥市場是更廣泛的醫療保健產業的重要組成部分，涵蓋了用於製備獸藥的基本化學化合物和生物物質。獸用原料藥是用於治療、預防和控制伴侶動物、家畜和水產養殖物種疾病的藥物產品中的關鍵治療成分。
由於人們對動物健康的日益關注、寵物飼養率的上升、動物蛋白消費需求的成長以及食品安全和動物福利標準方面嚴格法規的實施，獸用原料藥市場的重要性日益凸顯。獸用原料藥市場涵蓋多種類別，例如抗感染劑、驅蟲藥、抗發炎藥、麻醉劑和激素，每種類別都滿足獸醫學中特定的治療需求。
市場動態受多種因素影響，例如通用感染疾病的出現、動物醫藥研究的進步、為滿足全球食品需求而增加的畜牧業、寵物人性化趨勢的興起等等。此外，動物醫藥研發和核准流程的法律規範在塑造各地區的市場成長模式和競爭格局方面也發揮著至關重要的作用。
市場動態
全球獸用原料藥市場成長的主要驅動力是寵物飼養量的快速成長以及伴侶動物醫療保健支出的不斷攀升，寵物飼主越來越將動物視為家庭成員，並要求提供高品質的醫療保健服務。全球肉品消費量量的成長和畜牧業生產的擴張促使人們呼籲加強動物健康管理，這反過來又推動了對獸用原料藥的需求，以確保動物福利和食品安全標準。
製藥生產領域的技術創新，特別是新型動物給藥系統和精準醫療方法的開發，正在創造新的成長機會。然而，市場也面臨許多阻礙因素。嚴格的法規結構要求進行廣泛的臨床試驗和漫長的核准流程，這增加了新動物醫藥上市時間和研發成本。
假冒仿冒品獸藥的存在構成嚴峻挑戰，尤其是在新興市場，嚴重影響市場信譽和病人安全。此外，農村和發展中地區獸醫短缺限制了市場滲透率和優質獸醫服務的可近性。
儘管面臨這些挑戰，新興市場仍蘊藏著巨大的發展機會。可支配收入的成長和動物保健意識的提高，正在創造尚未開發的市場潛力。隨著全球水產養殖業的持續擴張，用於水產養殖的原料藥開發代表著巨大的成長機會。此外，人們對預防性動物保健的日益重視，以及對有機和天然動物產品需求的成長，也為原料藥的開發和市場拓展開闢了新的途徑。
本次調查的主要特點
- 本報告對全球獸用原料藥市場進行了詳細分析，以 2025 年為基準年，給出了預測期（2026-2033 年）內的市場規模（十億美元）和復合年成長率（%）。
- 我們將重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
- 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 本報告根據以下參數介紹了全球獸用原料藥市場主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
- 本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 這份全球獸用原料藥市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過各種用於分析全球獸用原料藥市場的策略矩陣輕鬆做出決策。
目錄
第1章 研究目標與前提條件
- 調查目的
- 先決條件
- 簡稱
第2章 市場範圍
- 報告概述
- 市場定義和範圍
- 執行摘要
第3章 市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 法規環境
- 產品上市及核准情況
- PEST分析
- 波特分析
- 市場機遇
- 法規環境
- 重大進展
- 產業趨勢
4. 2021-2033年全球獸用活性原料藥市場（依類型分類）
- 抗感染藥物
- 抗發炎藥
- 抗寄生蟲藥物
- 荷爾蒙和類固醇
- 維生素和營養素
- 麻醉劑
- 其他成分（例如，皮膚科原料藥、電解質）
5. 2021-2033年全球獸用原料藥市場（依動物種類分類）
- 伴侶動物
- 家畜
6. 2021-2033年全球獸用原料藥市場（以劑型分類）
- 固態的
- 液體
7. 2021-2033年全球獸用原料藥市場（依治療應用分類）
- 感染疾病控制
- 疼痛和炎症管理
- 寄生蟲控制
- 代謝和內分泌紊亂
- 生殖健康
- 營養支持
- 麻醉和鎮靜
- 其他（例如，皮膚科）
8. 2021-2033年全球獸用原料藥市場（依給藥途徑分類）
- 口服
- 腸外
- 外用
- 黏膜
9. 2021-2033年全球獸用原料藥市場（依生產類型分類）
- 契約製造
- 內部生產
10. 2021-2033年全球獸用原料藥市場依銷售管道
- 線上
- 離線
11. 2021-2033年全球獸用原料藥市場（依地區分類）
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第12章 競爭格局
- Zoetis Inc
- SUANFARMA SA
- Grupo Indukern SL
- Sequent Scientific Limited
- Ofichem Group
- Alivira Animal Health Limited
- Excel Industries Ltd
- Chempro Pharma Private Limited
- NGL Fine Chem Ltd
- FIS-Fabbrica Italiana Sintetici SpA
- AMGIS Lifescience Ltd
- Huvepharma AD
- Vetpharma Animal Health SL
- Qilu Animal Health Products Co Ltd
- Menadiona
第13章 分析師建議
- 機會
- 分析師觀點
- Coherent Opportunity Map
第14章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
Veterinary API Market is estimated to be valued at USD 9.97 Bn in 2026 and is expected to reach USD 16.43 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9.97 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.40% | 2033 Value Projection: | USD 16.43 Bn |
The global veterinary API market represents a critical segment within the broader animal healthcare industry, encompassing the fundamental chemical compounds and biological substances used in the formulation of veterinary medicines. Veterinary APIs serve as the primary therapeutic components in medications designed to treat, prevent, and manage diseases across companion animals, livestock, and aquaculture species.
This market has gained significant prominence due to the increasing awareness of animal health, rising pet ownership rates, growing demand for animal protein consumption, and the implementation of stringent regulations regarding food safety and animal welfare standards. The veterinary API landscape comprises various categories including anti-infectives, parasiticides, anti-inflammatory agents, anesthetics, and hormones, each addressing specific therapeutic needs within veterinary medicine.
The market dynamics are influenced by factors such as the emergence of zoonotic diseases, advancement in veterinary pharmaceutical research, increasing livestock production to meet global food demand, and the growing trend of pet humanization. Additionally, the regulatory framework governing veterinary drug development and approval processes plays a crucial role in shaping market growth patterns and competitive landscapes across different geographical regions.
Market Dynamics
The global veterinary API market growth is primarily driven by the exponential growth in pet ownership and the increasing expenditure on companion animal healthcare, as pet owners increasingly view their animals as family members requiring premium medical care. The rising global meat consumption and expanding livestock industry necessitate enhanced animal health management, driving demand for veterinary APIs to ensure animal welfare and food safety standards.
Technological advancements in pharmaceutical manufacturing, including the development of novel drug delivery systems and precision medicine approaches for animals, are creating new growth opportunities. However, the market faces significant restraints including stringent regulatory frameworks that require extensive clinical trials and lengthy approval processes, increasing the time-to-market and development costs for new veterinary APIs.
The presence of counterfeit and substandard veterinary medicines poses serious challenges, particularly in emerging markets, affecting market credibility and patient safety. Additionally, the limited number of veterinarians in rural areas and developing regions restricts market penetration and accessibility to quality veterinary care.
Despite these challenges, substantial opportunities exist in the form of emerging markets expansion, where increasing disposable income and growing awareness about animal health are creating untapped potential. The development of APIs for aquaculture applications presents significant growth prospects as fish farming continues to expand globally. Furthermore, the increasing focus on preventive healthcare in animals, coupled with the growing trend of organic and natural veterinary products, opens new avenues for API development and market expansion.
Key Features of the Study
- This report provides in-depth analysis of the global veterinary API market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global veterinary API market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Zoetis Inc, SUANFARMA S.A, Grupo Indukern S.L, Sequent Scientific Limited, Ofichem Group, Alivira Animal Health Limited, Excel Industries Ltd, Chempro Pharma Private Limited, NGL Fine Chem Ltd, FIS - Fabbrica Italiana Sintetici S.p.A, AMGIS Lifescience Ltd, Huvepharma AD, Vetpharma Animal Health S.L, Qilu Animal Health Products Co Ltd, and Menadiona
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global veterinary API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary API market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Anti infectives
- Anti inflammatory Drugs
- Antiparasitic Agents
- Hormones and Steroids
- Vitamins and Nutrients
- Anesthetics
- Others (e.g., Dermatological APIs, Electrolytes)
- Animal Type Insights (Revenue, USD Bn, 2021 - 2033)
- Companion Animals
- Dogs
- Cats
- Others (e.g., rabbits, birds)
- Livestock
- Cattle
- Swine
- Poultry
- Sheep and Goats
- Others (e.g., equine)
- Formulation Insights (Revenue, USD Bn, 2021 - 2033)
- Solid
- Tablets
- Capsules
- Powders
- Semi solid
- Ointments
- Gels
- Liquid
- Injectables
- Oral Solutions/Suspensions
- Therapeutic Application Insights (Revenue, USD Bn, 2021 - 2033)
- Infectious Disease Management
- Pain/Inflammation Management
- Parasitic Control
- Metabolic and Endocrine Disorders
- Reproductive Health
- Nutritional Support
- Anesthesia/Sedation
- Others (e.g., Dermatology)
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Parenteral
- Topical
- Mucosal
- Manufacturing Type Insights (Revenue, USD Bn, 2021 - 2033)
- Contract Manufacturing
- In house Manufacturing
- Sales Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Online
- Offline
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Zoetis Inc
- SUANFARMA S.A
- Grupo Indukern S.L
- Sequent Scientific Limited
- Ofichem Group
- Alivira Animal Health Limited
- Excel Industries Ltd
- Chempro Pharma Private Limited
- NGL Fine Chem Ltd
- FIS - Fabbrica Italiana Sintetici S.p.A
- AMGIS Lifescience Ltd
- Huvepharma AD
- Vetpharma Animal Health S.L
- Qilu Animal Health Products Co Ltd
- Menadiona
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Veterinary API Market, By Type
- Global Veterinary API Market, By Animal Type
- Global Veterinary API Market, By Formulation
- Global Veterinary API Market, By Therapeutic Application
- Global Veterinary API Market, By Route of Administration
- Global Veterinary API Market, By Manufacturing Type
- Global Veterinary API Market, By Sales Channel
- Global Veterinary API Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Veterinary API Market, By Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Anti infectives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anti inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Antiparasitic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hormones and Steroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Vitamins and Nutrients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (e.g., Dermatological APIs, Electrolytes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Veterinary API Market, By Animal Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Companion Animals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Dogs
- Cats
- Others (e.g., rabbits, birds)
- Livestock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cattle
- Swine
- Poultry
- Sheep and Goats
- Others (e.g., equine)
6. Global Veterinary API Market, By Formulation, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Solid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Tablets
- Capsules
- Powders
- Semi solid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ointments
- Gels
- Liquid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Injectables
- Oral Solutions/Suspensions
7. Global Veterinary API Market, By Therapeutic Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Infectious Disease Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pain/Inflammation Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Parasitic Control
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Metabolic and Endocrine Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Nutritional Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anesthesia/Sedation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (e.g., Dermatology)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Veterinary API Market, By Route of Administration, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mucosal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Veterinary API Market, By Manufacturing Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Contract Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- In house Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
10. Global Veterinary API Market, By Sales Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
11. Global Veterinary API Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Zoetis Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SUANFARMA S.A
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grupo Indukern S.L
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sequent Scientific Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ofichem Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alivira Animal Health Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Excel Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Chempro Pharma Private Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NGL Fine Chem Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- FIS - Fabbrica Italiana Sintetici S.p.A
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AMGIS Lifescience Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Huvepharma AD
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vetpharma Animal Health S.L
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qilu Animal Health Products Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Menadiona
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
